Patents by Inventor Kira Vladimirovna Rubtsova

Kira Vladimirovna Rubtsova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230111363
    Abstract: The present invention relates to antibodies that specifically bind human monocarboxylate transporter 1 (MCT1) (“anti-human MCT1 antibodies”), compositions comprising such anti-human MCT1 antibodies, and methods of using such anti-human MCT1 antibodies.
    Type: Application
    Filed: September 14, 2022
    Publication date: April 13, 2023
    Inventors: Frank Charles Dorsey, Joseph Benjamin Granger, Kira Vladimirovna Rubtsova, Oliver Schroeder, Wei Wang
  • Patent number: 11623956
    Abstract: The present disclosure relates to antibodies that bind human CD19 (“anti-human CD19 antibodies” or “anti-human CD19 antibodies”), compositions comprising such anti-human CD19 antibodies, and methods of using such anti-human CD19 antibodies.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: April 11, 2023
    Assignee: Eli Lilly and Company
    Inventors: Barrett Allan, Jeffrey Streetman Boyles, Alison Lee Sim Budelsky, Kira Vladimirovna Rubtsova, Guifeng Zhang, Songqing Na
  • Publication number: 20210269520
    Abstract: The present disclosure relates to antibodies that bind human CD19 (“anti-human CD19 antibodies” or “anti-human CD19 antibodies”), compositions comprising such anti-human CD19 antibodies, and methods of using such anti-human CD19 antibodies.
    Type: Application
    Filed: February 22, 2021
    Publication date: September 2, 2021
    Inventors: Barrett Allan, Jeffrey Streetman Boyles, Alison Lee Sim Budelsky, Kira Vladimirovna Rubtsova, Guifeng Zhang, Songqing Na